This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Delivered as Hybrid Event from 15-19 November 2021
Live In-Person Conference Delivered 15-17 NovemberSheraton Airport Brussels, Belgium

Sandra Von Meier PhD
Director Oncology Licensing & Business Development at Merck


Sandra joined Merck in 2014 as Director Business Development Oncology. During her 6 years within Business Development she led numerous transactions, evaluations and due diligences, supporting the transformation of Merck Healthcare KGaA into a leading global oncology company. Before Merck, Sandra was leading the Business Development activities at Medigene, a publicly listed German biotechnology company where she also closed several oncology transactions. Sandra studied Biochemistry at the FU Berlin and then moved to London in 1995 for her Diploma at the Institute of Cancer Research. In 1996 she was awarded a joint PhD scholarship from the Ludwig Institute for Cancer Research in London in collaboration with GlaxoSmithKline in Stevenage, UK. Sandra received her PhD from University College London in 1999.

Agenda Sessions

  • Panel Discussion: Product In-licensing: Sourcing Assets to Suit Your Portfolio